icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir and Ledipasvir Fixed-Dose Combination with and without Ribavirin in Treatment-Naïve and Previously Treated Patients with Genotype 1 Hepatitis C: The LONESTAR Study
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
 
Eric Lawitz1,2, Fred F. Poordad1,2, Phillip S. Pang3,
Robert H. Hyland3, Xiao Ding3, Hongmei Mo3, William T. Symonds3, John G. McHutchison3, Fernando E. Membreno1,2
1Texas Liver Institute, San Antonio, TX; 2University of Texas Health Science Center, San Antonio, TX; 3Gilead Sciences, Inc, Foster City, CA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif